3 May 2019 - Sask. just announced it will fund a drug that may relieve rapid degeneration caused by MS.
When Saskatchewan announced this week it has started covering the cost of a new multiple sclerosis drug, at least 50 people in the province who previously had no Health Canada-approved treatment options were already using it.
Lyle Daniels was one of them.
Daniels was offered the drug, called Ocrevus, for free on a trial basis soon after Health Canada approved it in early 2018.